KIMS.NS
KIMS.NS
INE967H01025
KRISHNA INST OF MED SCI L
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 55/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)
0.27x
Defensive
Volatility (5Y p.a.)
29.9% p.a.
5-Year Horizon
Max Drawdown (5Y)
-26.3%
5-Year Horizon
Sharpe Ratio
0.75
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +2.2%
3 Years 28.8% -26.3% 0.69 +22.4%
5 Years 29.9% -26.3% 0.75 +24.6%
10 Years — — — —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 138.3 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (29.9% p.a.).
ende